American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease

AGA Institute Clinical Practice and Quality Management Committee, Jonathan P Terdiman, Claudia B Gruss, Joel J Heidelbaugh, Shahnaz Sultan, Yngve T Falck-Ytter, David S. Weinberg

Research output: Contribution to journalArticlepeer-review

200 Scopus citations
Original languageEnglish
Pages (from-to)1459-63
Number of pages5
JournalGastroenterology
Volume145
Issue number6
DOIs
StatePublished - Nov 2013

Keywords

  • Azathioprine/therapeutic use
  • Crohn Disease/drug therapy
  • Gastroenterology
  • Humans
  • Mercaptopurine/therapeutic use
  • Methotrexate/therapeutic use
  • Remission Induction
  • Societies, Medical
  • Tumor Necrosis Factor-alpha/antagonists & inhibitors
  • United States

Fingerprint

Dive into the research topics of 'American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease'. Together they form a unique fingerprint.

Cite this